COCH
HEALTHCAREEnvoy Medical Inc - Class A
$0.68-0.02 (-3.07%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving COCH Today?
No stock-specific AI insight has been generated for COCH yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.36$1.91
$0.68
Fundamentals
Market Cap$52M
P/E Ratio—
EPS$-1.23
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume72K
Avg Volume (10D)—
Shares Outstanding76.9M
COCH News
20 articles- TransMedics (TMDX) Q1 Earnings and Revenues Miss EstimatesYahoo Finance·May 5, 2026
- Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear ImplantYahoo Finance·Apr 28, 2026
- Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear ImplantYahoo Finance·Apr 22, 2026
- Envoy Medical Appoints Chas McKhann to Board of DirectorsYahoo Finance·Apr 16, 2026
- Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear ImplantYahoo Finance·Apr 1, 2026
- Envoy Medical Reports Full Year 2025 Financial ResultsYahoo Finance·Mar 23, 2026
- Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear ImplantYahoo Finance·Mar 11, 2026
- Envoy Medical Regains Compliance with Nasdaq Listing RequirementYahoo Finance·Feb 24, 2026
- Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing SpaceYahoo Finance·Feb 23, 2026
- Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical TrialYahoo Finance·Feb 19, 2026
- Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear ImplantYahoo Finance·Feb 17, 2026
- Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public OfferingYahoo Finance·Feb 12, 2026
- Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public OfferingYahoo Finance·Feb 11, 2026
- Small Cap Growth Virtual Investor Conference: Presentations Now Available for On-Demand ViewingYahoo Finance·Feb 6, 2026
- Small Cap Growth Virtual Investor Conference Agenda Announced for February 5thYahoo Finance·Feb 2, 2026
- Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5Yahoo Finance·Jan 29, 2026
- Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear ImplantYahoo Finance·Dec 18, 2025
- Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise RatioYahoo Finance·Dec 16, 2025
- Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear ImplantYahoo Finance·Dec 10, 2025
- Positive Signs As Multiple Insiders Buy Envoy Medical StockYahoo Finance·Dec 9, 2025
All 20 articles loaded
Price Data
Open$0.67
Previous Close$0.70
Day High$0.70
Day Low$0.67
52 Week High$1.91
52 Week Low$0.36
52-Week Range
$0.36$1.91
$0.68
Fundamentals
Market Cap$52M
P/E Ratio—
EPS$-1.23
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume72K
Avg Volume (10D)—
Shares Outstanding76.9M
About Envoy Medical Inc - Class A
Envoy Medical Corporation manufactures and markets an implantable hearing aid device. The company is headquartered in White Bear Lake, Minnesota.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—